SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-19-000064
Filing Date
2019-08-08
Accepted
2019-08-08 16:23:48
Documents
114
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-06302019x10q.htm   iXBRL 10-Q 7563999
2 AMENDMENT NO 6 TO THE PFIZER SUPPLEMENTAL SAVINGS PLAN pfe-630201910qxexh101.htm EX-10.1 8977
3 ACCOUNTANTS' ACKNOWLEDGEMENT pfe-0630201910qexh15.htm EX-15 8071
4 CERTIFICATION BY THE CEO - SECTION 302 pfe-0630201910qxexh311.htm EX-31.1 9793
5 CERTIFICATION BY THE CFO - SECTION 302 pfe-0630201910qxexh312.htm EX-31.2 9940
6 CERTIFICATION BY THE CEO - SECTION 1350 pfe-0630201910qxexh321.htm EX-32.1 6716
7 CERTIFICATION BY THE CFO - SECTION 1350 pfe-0630201910qxexh322.htm EX-32.2 6666
13 firstsixmonths2018revbyseg.jpg GRAPHIC 16669
14 firstsixmonths2019revbyseg.jpg GRAPHIC 16638
15 pfizerlogo2816.jpg GRAPHIC 15668
16 q22018revenuesbysegment.jpg GRAPHIC 16569
17 q22019revenuesbysegment.jpg GRAPHIC 16245
18 upjohnlogo.jpg GRAPHIC 230605
  Complete submission text file 0000078003-19-000064.txt   27894500

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20190630.xsd EX-101.SCH 109851
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20190630_cal.xml EX-101.CAL 210150
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20190630_def.xml EX-101.DEF 606496
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20190630_lab.xml EX-101.LAB 1326336
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20190630_pre.xml EX-101.PRE 809709
19 EXTRACTED XBRL INSTANCE DOCUMENT pfe-06302019x10q_htm.xml XML 7349515
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 191009913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences